March 3, 2021
Health News

This Is the Best News Yet for Moderna’s COVID Vaccine – The Motley Fool

Moderna(NASDAQ:MRNA) has announced its share of good news in the past couple of months. The biotech company generated positive results in the phase 3 trial of its investigational coronavirus vaccine. Then, the U.S. Food and Drug Administration granted the product Emergency Use Authorization in the weeks that followed. Moderna also has signed advance purchase agreements for 2021 that represent more than $11 billion in revenue. That’s a big deal for a company that didn’t have product revenue just…

Click here to view the original article.

Related Posts

You might also like ...

Article feature image
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England – Science
Article feature image
Hydroxychloroquine not recommended for coronavirus treatment: WHO panel – Fox News
Article feature image
Two more Mainers with COVID-19 have died as total cases top 45,000 – WMTW Portland